Citadel Advisors’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72M | Sell |
|
|||||
|
2025
Q1 | $1.74M | Sell |
|
|||||
|
2024
Q4 | $4.12M | Buy |
|
|||||
|
2024
Q3 | $2.23M | Sell |
|
|||||
|
2024
Q2 | $2.39M | Buy |
|
|||||
|
2024
Q1 | $3.63M | Hold |
|
|||||
|
2023
Q4 | $2.75M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $8.09K | Sell |
|
|||||
|
2022
Q3 | $19K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $29K | Buy |
|
|||||
|
2021
Q4 | $33K | Sell |
|
|||||
|
2021
Q3 | $81K | Buy |
|
|||||
|
2021
Q2 | $116K | Buy |
|
|||||
|
2021
Q1 | – | Hold |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $875K | Buy |
|
|||||
|
2020
Q1 | $42K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $57K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $130K | Buy |
|
|||||
|
2018
Q1 | $535K | Buy |
|